SCHEMBL19854444

SCHEMBL19854444

C=CC(=O)NCCOc1ccc(-c2ccc(-c3ccc(C4CCC(CCCCC)CC4)cc3)cc2F)cc1F

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 4/20 0.40
▸ ITK Q08881 1/20 0.38
▸ PPARD Q03181 3/20 0.37
▸ FFAR4 Q5NUL3 2/20 0.36
▸ DGAT1 O75907 1/20 0.35
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ S1PR1 P21453 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RARA P10276 1/20 0.33
▸ RARB P10826 1/20 0.33
▸ CDK7 P50613 1/20 0.32
▸ CDK13 Q14004 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19855141 0.96 ITK (0.41) BTKITKPPARDFFAR4DGAT1
SCHEMBL19853813 0.92 DGAT1 (0.40) BTKITKFFAR4DGAT1CYP2C9
SCHEMBL19855117 0.91 BTK (0.43) BTKITKFFAR4DGAT1CYP3A4
SCHEMBL19855821 0.91 RARB (0.40) BTKITKFFAR4DGAT1CYP3A4
SCHEMBL19855114 0.90 BTK (0.40) BTKITKPPARDFFAR4CYP3A4
SCHEMBL19856027 0.89 ITK (0.44) BTKITKS1PR1EGFRKDR
SCHEMBL19854183 0.89 BTK (0.39) BTKITKPPARDDGAT1S1PR1
SCHEMBL19855145 0.88 ITK (0.39) BTKITKPPARDFFAR4DGAT1
SCHEMBL19854169 0.87 RARA (0.40) BTKFFAR4DGAT1CYP3A4CYP2C9
SCHEMBL19856050 0.87 ITK (0.43) BTKITKS1PR1EGFRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed
WO-2018025974-A1 LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE JNC株式会社 2018-02-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, MBD2, PAXBP1 BTK 4463/4885ITK 4240/4885PPARD 1343/4885
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device SP1, MBD2, PAXBP1 BTK 4463/4885ITK 4240/4885PPARD 1343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback